在非小细胞肺癌中Oligo复发和治疗选择的特征
Dai Sonoda1,2, Yasuto Kondo1, Satoru Tamagawa1,3
1Department of Thoracic Surgery, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara 252-0374, Kanagawa, Japan.
Cancers
|July 29, 2025
概括
治疗复发性非小细胞肺癌 (NSCLC) 是一个挑战. 奥利戈复发,转移很少,有可能通过局部治疗和先进的全身治疗来治愈.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
背景情况:
- 非小细胞肺癌 (NSCLC) 治疗已取得进展,但切除后复发仍然是一个挑战.
- 奥利戈复发,特别是超时复发,提供了通过局部疗法治愈的机会.
- 系统性治疗,如向疗法和免疫检查点抑制剂,改善了NSCLC的预后.
研究的目的:
- 审查目前关于原复发性NSCLC的证据.
- 讨论原复发性NSCLC的临床特征和治疗策略.
主要方法:
- 追溯和正在进行的前性试验的叙述性审查.
- 分析治疗选择,包括向治疗,免疫检查点抑制剂和化疗.
主要成果:
- 在没有疾病的间隔后,具有有限转移的特征的Oligo复发是重点关注的重点.
- 对原复发性NSCLC的有效治疗选择是复杂的,需要平衡局部和全身的选择.
结论:
- 局部和全身疗法的进步为复发性NSCLC提供了更好的结果.
- 针对原复发性NSCLC的量身定制治疗需要仔细考虑各种治疗方式.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.2K
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
10.7K
相关概念视频
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
